broad_id
string | depmap_id
string | ccle_name
string | screen_id
string | upper_limit
int64 | lower_limit
float64 | slope
float64 | r2
float64 | auc
float64 | ec50
float64 | ic50
float64 | name
string | moa
string | target
string | disease.area
string | indication
string | smiles
string | phase
string | passed_str_profiling
bool | row_name
string |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BRD-A98990573-003-01-3
|
ACH-000367
|
NCIH226_LUNG
|
HTS002
| 1 | 2.478964 | 0.057529 | -0.037068 | 1.433468 | 380,001.249781 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000367
|
BRD-A98990573-003-01-3
|
ACH-001190
|
SKMEL2_SKIN
|
HTS002
| 1 | 1.246811 | -0.015808 | -0.229736 | 1.150525 | 149,107,225,833.317 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-001190
|
BRD-A98990573-003-01-3
|
ACH-000713
|
CAOV3_OVARY
|
HTS002
| 1 | 1.346589 | 0.135358 | 0.001704 | 1.168214 | 0.122368 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000713
|
BRD-A98990573-003-01-3
|
ACH-000672
|
IALM_LUNG
|
HTS002
| 1 | 3.397769 | -0.115197 | 0.097976 | 1.771578 | 0.000103 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000672
|
BRD-A98990573-003-01-3
|
ACH-000875
|
NCIH2347_LUNG
|
HTS002
| 1 | 2.050145 | 0.171866 | 0.013351 | 1.467693 | 0.301243 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000875
|
BRD-A98990573-003-01-3
|
ACH-000423
|
SKMEL3_SKIN
|
HTS002
| 1 | 1.550757 | 0.143829 | 0.003124 | 1.296959 | 0.02509 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000423
|
BRD-A98990573-003-01-3
|
ACH-000553
|
SQ1_LUNG
|
HTS002
| 1 | 1.429767 | 0.050656 | -0.045753 | 1.211948 | 0.134356 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000553
|
BRD-A98990573-003-01-3
|
ACH-000834
|
UMUC1_URINARY_TRACT
|
HTS002
| 1 | 2.420943 | -0.386907 | 0.025175 | 1.570848 | 0.02106 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000834
|
BRD-A98990573-003-01-3
|
ACH-000252
|
LS1034_LARGE_INTESTINE
|
HTS002
| 1 | 1.764826 | 0.318103 | 0.075741 | 1.460723 | 0.016555 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000252
|
BRD-A98990573-003-01-3
|
ACH-000123
|
COV434_OVARY
|
HTS002
| 1 | 1.871036 | 0.971387 | 0.042252 | 1.23525 | 0.790329 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000123
|
BRD-A98990573-003-01-3
|
ACH-000329
|
CCFSTTG1_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | 2.043009 | -0.033437 | -0.174835 | 1.543977 | 1.035926 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000329
|
BRD-A98990573-003-01-3
|
ACH-000717
|
COLO680N_OESOPHAGUS
|
HTS002
| 1 | 1.78235 | -0.034124 | -0.001352 | 1.389012 | 0.056457 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000717
|
BRD-A98990573-003-01-3
|
ACH-000669
|
SW900_LUNG
|
HTS002
| 1 | 1.832861 | -0.00685 | -0.103785 | 1.426702 | 105.043676 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000669
|
BRD-A98990573-003-01-3
|
ACH-000764
|
SH10TC_STOMACH
|
HTS002
| 1 | 1.051229 | 0.112602 | -0.402757 | 1.030866 | 0.001776 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000764
|
BRD-A98990573-003-01-3
|
ACH-000288
|
BT549_BREAST
|
HTS002
| 1 | 1.701641 | 0.191987 | 0.074533 | 1.347764 | 0.086103 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000288
|
BRD-A98990573-003-01-3
|
ACH-000228
|
BICR31_UPPER_AERODIGESTIVE_TRACT
|
HTS002
| 1 | 2.25861 | 0.069242 | 0.033481 | 1.551604 | 2.911644 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000228
|
BRD-A98990573-003-01-3
|
ACH-000977
|
LNCAPCLONEFGC_PROSTATE
|
HTS002
| 1 | 0.971757 | 0.693095 | -0.229357 | 0.983601 | 0.033669 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000977
|
BRD-A98990573-003-01-3
|
ACH-000397
|
TEN_ENDOMETRIUM
|
HTS002
| 1 | 2.376421 | -0.009003 | -0.041521 | 1.814746 | 68,925,885,048,248,780 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000397
|
BRD-A98990573-003-01-3
|
ACH-000565
|
RCM1_LARGE_INTESTINE
|
HTS002
| 1 | 1.558587 | -0.55099 | 0.033954 | 1.278205 | 0.076446 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000565
|
BRD-A98990573-003-01-3
|
ACH-000927
|
BT474_BREAST
|
HTS002
| 1 | 1.343573 | -0.196606 | -0.171738 | 1.231561 | 4.08948 | null |
epinastine
|
histamine receptor antagonist
|
ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7
|
ophthalmology
|
conjunctivitis
|
NC1=NCC2N1c1ccccc1Cc1ccccc21
|
Launched
| true |
ACH-000927
|
BRD-K47832606-001-30-1
|
ACH-000879
|
MFE296_ENDOMETRIUM
|
HTS002
| 1 | 0.123092 | 7.885006 | 0.523307 | 0.726373 | 0.48411 | 0.501776 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000879
|
BRD-K47832606-001-30-1
|
ACH-000320
|
PSN1_PANCREAS
|
HTS002
| 1 | 0.10514 | 4.771221 | 0.972544 | 0.336463 | 0.007499 | 0.007879 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000320
|
BRD-K47832606-001-30-1
|
ACH-001145
|
OC316_OVARY
|
HTS002
| 1 | 0.099077 | 3.864619 | 0.803485 | 0.485618 | 0.039244 | 0.041552 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-001145
|
BRD-K47832606-001-30-1
|
ACH-000873
|
KYSE270_OESOPHAGUS
|
HTS002
| 1 | 0.060055 | 3.816708 | 0.775195 | 0.548483 | 0.094523 | 0.097745 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000873
|
BRD-K47832606-001-30-1
|
ACH-000855
|
KYSE150_OESOPHAGUS
|
HTS002
| 1 | 0.390028 | 5.593754 | 0.711406 | 0.631609 | 0.028491 | 0.037349 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000855
|
BRD-K47832606-001-30-1
|
ACH-000913
|
ESS1_ENDOMETRIUM
|
HTS002
| 1 | 0.27864 | 2.113099 | 0.413024 | 0.647397 | 0.087092 | 0.128069 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000913
|
BRD-K47832606-001-30-1
|
ACH-000558
|
A172_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | 0.219398 | 1.167315 | 0.603356 | 0.580288 | 0.054058 | 0.088671 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000558
|
BRD-K47832606-001-30-1
|
ACH-000593
|
BC3C_URINARY_TRACT
|
HTS002
| 1 | 0.285356 | 3.283477 | 0.629942 | 0.645974 | 0.0817 | 0.105699 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000593
|
BRD-K47832606-001-30-1
|
ACH-000488
|
TE11_OESOPHAGUS
|
HTS002
| 1 | 0.236216 | 3.808991 | 0.794521 | 0.598061 | 0.060558 | 0.071628 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000488
|
BRD-K47832606-001-30-1
|
ACH-000832
|
CAL27_UPPER_AERODIGESTIVE_TRACT
|
HTS002
| 1 | 0.278338 | 2.946289 | 0.812135 | 0.564635 | 0.028676 | 0.037794 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000832
|
BRD-K47832606-001-30-1
|
ACH-000781
|
NCIH2023_LUNG
|
HTS002
| 1 | 0.379814 | 9.909888 | 0.441305 | 0.690942 | 0.0794 | 0.091684 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000781
|
BRD-K47832606-001-30-1
|
ACH-000833
|
RH30_SOFT_TISSUE
|
HTS002
| 1 | 0.322819 | 1.710281 | 0.592769 | 0.543245 | 0.01433 | 0.026284 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000833
|
BRD-K47832606-001-30-1
|
ACH-000137
|
8MGBA_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | 0.188678 | 2.328343 | 0.757438 | 0.581448 | 0.066961 | 0.082072 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000137
|
BRD-K47832606-001-30-1
|
ACH-000632
|
HS944T_SKIN
|
HTS002
| 1 | 0.185653 | 3.906275 | 0.661074 | 0.560786 | 0.05333 | 0.060058 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000632
|
BRD-K47832606-001-30-1
|
ACH-000319
|
MPP89_PLEURA
|
HTS002
| 1 | 2.515378 | -0.014656 | -0.013553 | 1.771409 | 0.925875 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000319
|
BRD-K47832606-001-30-1
|
ACH-000630
|
YD8_UPPER_AERODIGESTIVE_TRACT
|
HTS002
| 1 | 0.425762 | 2.865641 | 0.030134 | 0.85194 | 0.819372 | 1.594198 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000630
|
BRD-K47832606-001-30-1
|
ACH-000266
|
SNU213_PANCREAS
|
HTS002
| 1 | 1.522356 | -6.680382 | 0.191283 | 1.111944 | 0.004884 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000266
|
BRD-K47832606-001-30-1
|
ACH-000047
|
GCIY_STOMACH
|
HTS002
| 1 | 0.223612 | 2.620157 | 0.775777 | 0.573586 | 0.048452 | 0.060754 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000047
|
BRD-K47832606-001-30-1
|
ACH-000273
|
SF539_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | 0.131052 | 4.46567 | 0.760405 | 0.492328 | 0.034496 | 0.036926 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000273
|
BRD-K47832606-001-30-1
|
ACH-000682
|
SNU1066_UPPER_AERODIGESTIVE_TRACT
|
HTS002
| 1 | 0.22864 | 2.817694 | 0.774301 | 0.572712 | 0.046286 | 0.057498 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000682
|
BRD-K47832606-001-30-1
|
ACH-000359
|
MG63_BONE
|
HTS002
| 1 | 0.293324 | 2.729806 | 0.654008 | 0.750275 | 0.324131 | 0.447995 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000359
|
BRD-K47832606-001-30-1
|
ACH-000846
|
FADU_UPPER_AERODIGESTIVE_TRACT
|
HTS002
| 1 | 0.101684 | 0.891676 | 0.883318 | 0.492464 | 0.040847 | 0.052711 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000846
|
BRD-K47832606-001-30-1
|
ACH-000804
|
NB1_AUTONOMIC_GANGLIA
|
HTS002
| 1 | 0.073301 | 1.959961 | 0.972829 | 0.421177 | 0.023306 | 0.025269 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000804
|
BRD-K47832606-001-30-1
|
ACH-000609
|
SF126_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | -0.038818 | 0.519385 | 0.784649 | 0.418278 | 0.030612 | 0.026508 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000609
|
BRD-K47832606-001-30-1
|
ACH-000974
|
SNGM_ENDOMETRIUM
|
HTS002
| 1 | 0.226438 | 3.244132 | 0.466407 | 0.649378 | 0.122966 | 0.148088 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000974
|
BRD-K47832606-001-30-1
|
ACH-000987
|
MEWO_SKIN
|
HTS002
| 1 | 0.149936 | 1.387641 | 0.812502 | 0.592523 | 0.095506 | 0.123481 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000987
|
BRD-K47832606-001-30-1
|
ACH-000787
|
LXF289_LUNG
|
HTS002
| 1 | 0.229243 | 5.140688 | 0.849299 | 0.521692 | 0.024247 | 0.02732 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000787
|
BRD-K47832606-001-30-1
|
ACH-000561
|
TT_OESOPHAGUS
|
HTS002
| 1 | 0.194131 | 3.821604 | 0.732601 | 0.536222 | 0.037549 | 0.042702 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000561
|
BRD-K47832606-001-30-1
|
ACH-000212
|
CAL120_BREAST
|
HTS002
| 1 | 0.169088 | 1.825458 | 0.844268 | 0.639196 | 0.147939 | 0.185473 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000212
|
BRD-K47832606-001-30-1
|
ACH-000753
|
JMSU1_URINARY_TRACT
|
HTS002
| 1 | 0.071853 | 1.297696 | 0.77363 | 0.652125 | 0.265021 | 0.298676 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000753
|
BRD-K47832606-001-30-1
|
ACH-000305
|
ECGI10_OESOPHAGUS
|
HTS002
| 1 | 0.33356 | 2.198212 | 0.786261 | 0.693634 | 0.115508 | 0.190516 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000305
|
BRD-K47832606-001-30-1
|
ACH-000138
|
CFPAC1_PANCREAS
|
HTS002
| 1 | 0.100176 | 0.899843 | 0.676359 | 0.409957 | 0.016351 | 0.020963 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000138
|
BRD-K47832606-001-30-1
|
ACH-000250
|
KMRC20_KIDNEY
|
HTS002
| 1 | 0.325036 | 5.218719 | 0.656166 | 0.666281 | 0.082467 | 0.100847 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000250
|
BRD-K47832606-001-30-1
|
ACH-000856
|
CAL51_BREAST
|
HTS002
| 1 | 0.242264 | 5.051557 | 0.81304 | 0.571427 | 0.041337 | 0.047131 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000856
|
BRD-K47832606-001-30-1
|
ACH-000046
|
ACHN_KIDNEY
|
HTS002
| 1 | 0.032024 | 2.346294 | 0.797691 | 0.441029 | 0.036839 | 0.037893 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000046
|
BRD-K47832606-001-30-1
|
ACH-000878
|
HCC15_LUNG
|
HTS002
| 1 | 0.292419 | 3.746697 | 0.852231 | 0.602022 | 0.042619 | 0.053889 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000878
|
BRD-K47832606-001-30-1
|
ACH-000766
|
NCIH1648_LUNG
|
HTS002
| 1 | 0.178486 | 6.801478 | 0.839077 | 0.530087 | 0.038843 | 0.041448 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000766
|
BRD-K47832606-001-30-1
|
ACH-000666
|
NCIH1355_LUNG
|
HTS002
| 1 | 0.486426 | 2.745142 | 0.401085 | 0.75265 | 0.093375 | 0.347363 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000666
|
BRD-K47832606-001-30-1
|
ACH-000014
|
HS294T_SKIN
|
HTS002
| 1 | 0.190261 | 3.40639 | 0.653899 | 0.546061 | 0.04339 | 0.04994 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000014
|
BRD-K47832606-001-30-1
|
ACH-000701
|
RMUGS_OVARY
|
HTS002
| 1 | 0.327732 | 1.554079 | 0.635325 | 0.641891 | 0.056868 | 0.112887 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000701
|
BRD-K47832606-001-30-1
|
ACH-000884
|
MDAMB435S_SKIN
|
HTS002
| 1 | 1.468327 | -2.133493 | 0.420368 | 1.246145 | 0.10014 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000884
|
BRD-K47832606-001-30-1
|
ACH-000037
|
S117_SOFT_TISSUE
|
HTS002
| 1 | 0.24471 | 2.80327 | 0.534332 | 0.647703 | 0.1082 | 0.137521 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000037
|
BRD-K47832606-001-30-1
|
ACH-000504
|
SNB75_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | 0.145945 | 4.673798 | 0.540869 | 0.601978 | 0.108622 | 0.116947 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000504
|
BRD-K47832606-001-30-1
|
ACH-000502
|
TCCPAN2_PANCREAS
|
HTS002
| 1 | 0.240968 | 4.698223 | 0.74694 | 0.646632 | 0.109136 | 0.125534 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000502
|
BRD-K47832606-001-30-1
|
ACH-000886
|
NCIH2009_LUNG
|
HTS002
| 1 | 0.053788 | 6.749659 | 0.887671 | 0.30824 | 0.008297 | 0.008438 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000886
|
BRD-K47832606-001-30-1
|
ACH-000035
|
NCIH1650_LUNG
|
HTS002
| 1 | 0.549551 | 8.693176 | 0.452271 | 0.773775 | 0.076459 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000035
|
BRD-K47832606-001-30-1
|
ACH-000661
|
WM1799_SKIN
|
HTS002
| 1 | 0.172981 | 0.997392 | 0.751888 | 0.459293 | 0.016976 | 0.025985 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000661
|
BRD-K47832606-001-30-1
|
ACH-000391
|
MHHES1_BONE
|
HTS002
| 1 | 0.057975 | 5.871609 | 0.689743 | 0.513058 | 0.066302 | 0.067708 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000391
|
BRD-K47832606-001-30-1
|
ACH-000843
|
HARA_LUNG
|
HTS002
| 1 | 0.266728 | 2.027041 | 0.643432 | 0.590675 | 0.044402 | 0.064677 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000843
|
BRD-K47832606-001-30-1
|
ACH-000711
|
JIMT1_BREAST
|
HTS002
| 1 | 0.258613 | 3.917281 | 0.331083 | 0.668526 | 0.130536 | 0.157205 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000711
|
BRD-K47832606-001-30-1
|
ACH-000232
|
U251MG_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | 0.111125 | 1.786807 | 0.673534 | 0.508229 | 0.046588 | 0.053625 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000232
|
BRD-K47832606-001-30-1
|
ACH-000060
|
PANC1005_PANCREAS
|
HTS002
| 1 | 0.365577 | 5.680825 | 0.614259 | 0.653408 | 0.049844 | 0.062812 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000060
|
BRD-K47832606-001-30-1
|
ACH-000322
|
HT144_SKIN
|
HTS002
| 1 | 0.156055 | 4.765827 | 0.456102 | 0.617693 | 0.123272 | 0.133339 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000322
|
BRD-K47832606-001-30-1
|
ACH-000736
|
SNU601_STOMACH
|
HTS002
| 1 | 0.064045 | 2.857174 | 0.893413 | 0.338135 | 0.010464 | 0.010978 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000736
|
BRD-K47832606-001-30-1
|
ACH-000809
|
KYSE410_OESOPHAGUS
|
HTS002
| 1 | 0.249972 | 1.284933 | 0.829526 | 0.563619 | 0.035185 | 0.060339 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000809
|
BRD-K47832606-001-30-1
|
ACH-000747
|
NCIH1703_LUNG
|
HTS002
| 1 | 0.104899 | 1.18601 | 0.90381 | 0.676512 | 0.303697 | 0.370394 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000747
|
BRD-K47832606-001-30-1
|
ACH-000364
|
U2OS_BONE
|
HTS002
| 1 | 1.435834 | -6.467609 | 0.29223 | 1.137719 | 0.013101 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000364
|
BRD-K47832606-001-30-1
|
ACH-000679
|
OE19_OESOPHAGUS
|
HTS002
| 1 | 0.23987 | 4.833581 | 0.682862 | 0.658406 | 0.127667 | 0.146147 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000679
|
BRD-K47832606-001-30-1
|
ACH-000985
|
LS411N_LARGE_INTESTINE
|
HTS002
| 1 | 0.148856 | 3.086933 | 0.699415 | 0.539835 | 0.052662 | 0.05905 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000985
|
BRD-K47832606-001-30-1
|
ACH-000441
|
SH4_SKIN
|
HTS002
| 1 | 0.502221 | 5.618827 | 0.659641 | 0.770076 | 0.113072 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000441
|
BRD-K47832606-001-30-1
|
ACH-001113
|
LC1SQSF_LUNG
|
HTS002
| 1 | 0.482338 | 3.09893 | 0.214854 | 0.764082 | 0.12004 | 0.353063 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-001113
|
BRD-K47832606-001-30-1
|
ACH-000620
|
JHH1_LIVER
|
HTS002
| 1 | 0.655783 | 9.945614 | 0.358919 | 0.827884 | 0.078108 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000620
|
BRD-K47832606-001-30-1
|
ACH-000853
|
NCIH661_LUNG
|
HTS002
| 1 | 0.52168 | 2.862689 | 0.48102 | 0.768694 | 0.091619 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000853
|
BRD-K47832606-001-30-1
|
ACH-000102
|
GMS10_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | 0.250206 | 1.810383 | 0.68131 | 0.579092 | 0.04306 | 0.063176 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000102
|
BRD-K47832606-001-30-1
|
ACH-000648
|
NCIH28_PLEURA
|
HTS002
| 1 | 0.28697 | 7.031266 | 0.539409 | 0.666134 | 0.10633 | 0.120048 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000648
|
BRD-K47832606-001-30-1
| null | null |
HTS002
| 1 | 0.131836 | 1.959351 | 0.906137 | 0.401642 | 0.012437 | 0.01454 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| false |
ACH-000925_FAILED_STR
|
BRD-K47832606-001-30-1
|
ACH-001239
|
WM2664_SKIN
|
HTS002
| 1 | 0.163677 | 2.237879 | 0.855226 | 0.565935 | 0.064959 | 0.077552 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-001239
|
BRD-K47832606-001-30-1
|
ACH-001321
|
TT_THYROID
|
HTS002
| 1 | 0.384921 | 3.278042 | 0.722054 | 0.835351 | 0.744516 | 1.165452 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-001321
|
BRD-K47832606-001-30-1
|
ACH-000279
|
EWS502_BONE
|
HTS002
| 1 | 0.062731 | 1.855873 | 0.74678 | 0.431616 | 0.027802 | 0.029884 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000279
|
BRD-K47832606-001-30-1
|
ACH-000172
|
TM87_SOFT_TISSUE
|
HTS002
| 1 | 0.110156 | 3.392582 | 0.895632 | 0.5249 | 0.056216 | 0.060494 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000172
|
BRD-K47832606-001-30-1
|
ACH-001128
|
MON_SOFT_TISSUE
|
HTS002
| 1 | 0.125018 | 9.151695 | 0.585093 | 0.569529 | 0.08445 | 0.087147 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-001128
|
BRD-K47832606-001-30-1
|
ACH-000437
|
SW1088_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | 0.109291 | 1.89719 | 0.694857 | 0.393217 | 0.013438 | 0.015304 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000437
|
BRD-K47832606-001-30-1
|
ACH-000735
|
PECAPJ49_UPPER_AERODIGESTIVE_TRACT
|
HTS002
| 1 | 0.09273 | 1.218993 | 0.882721 | 0.39397 | 0.015064 | 0.017824 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000735
|
BRD-K47832606-001-30-1
|
ACH-000643
|
HDQP1_BREAST
|
HTS002
| 1 | 0.379726 | 7.466043 | 0.719555 | 0.696771 | 0.087041 | 0.105343 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000643
|
BRD-K47832606-001-30-1
|
ACH-000207
|
DETROIT562_UPPER_AERODIGESTIVE_TRACT
|
HTS002
| 1 | 0.266922 | 3.327026 | 0.572965 | 0.590454 | 0.044212 | 0.055612 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000207
|
BRD-K47832606-001-30-1
|
ACH-000456
|
BCPAP_THYROID
|
HTS002
| 1 | 0.054028 | 0.735584 | 0.795512 | 0.506728 | 0.062682 | 0.073225 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000456
|
BRD-K47832606-001-30-1
|
ACH-000260
|
SKNAS_AUTONOMIC_GANGLIA
|
HTS002
| 1 | 0.219911 | 5.482424 | 0.412103 | 0.558627 | 0.041256 | 0.045855 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000260
|
BRD-K47832606-001-30-1
|
ACH-000019
|
MCF7_BREAST
|
HTS002
| 1 | 0.331773 | 1.034922 | 0.695635 | 0.706686 | 0.142477 | 0.408183 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000019
|
BRD-K47832606-001-30-1
|
ACH-000582
|
COLO741_SKIN
|
HTS002
| 1 | 0.26895 | 1.045834 | 0.580407 | 0.71155 | 0.220731 | 0.461781 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000582
|
BRD-K47832606-001-30-1
|
ACH-000990
|
HEC108_ENDOMETRIUM
|
HTS002
| 1 | 0.346441 | 3.549785 | 0.620228 | 0.650627 | 0.055859 | 0.077898 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000990
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.